Журнал "Почки" том 10, №3

Çàïðîøåí³ ñòàòò³ / Guest Articles
References
1. Fishman J.A. Infection in solid-organ transplant recipients. The
New England journal of medicine. 2007 Dec 20. 357(25). 2601-14.
2. Kasiske B.L., Snyder J.J., Gilbertson D.T., Wang C. Cancer
after kidney transplantation in the United States. American journal of
transplantation: official journal of the American Society of Transplantation
and the American Society of Transplant Surgeons. 2004 Jun.
4(6). 905-13.
3. Ojo A.O., Held P.J., Port F.K., Wolfe R.A., Leichtman A.B.,
Young E.W. et al. Chronic renal failure after transplantation of a
nonrenal organ. The New England journal of medicine. 2003 Sep 4.
349(10). 931-40.
4. Li L., Wozniak L.J., Rodder S., Heish S., Talisetti A., Wang Q.,
Esquivel C., Cox K., Chen R., Mcdiarmid S.V., Sarwal M.M. A common
peripheral blood gene set for diagnosis of operational tolerance
in pediatric and adult liver transplantation. Am. J. Transplant. 2012.
12. 1218-1228.
5. Bohne F., Martinez-Llordella M., Lozano J.J. et al. Intra-graft
expression of genes involved in iron homeostasis predicts the development
of operational tolerance in human liver transplantation. J. Clin.
Invest. 2012. 122. 368-382.
6. Sagoo P., Perucha E., Sawitzki B. et al. Development of a
cross-platform biomarker signature to detect renal transplant tolerance
in humans. J. Clin. Invest. 2010. 120. 1848-1861.
7. Ashton-Chess J., Giral M., Brouard S., Soulillou J.P. Spontaneous
operational tolerance after immunosuppressive drug withdrawal
in clinical renal allotransplantation. Transplantation. 2007.
84. 1215-1219.
8. Orlando G., Hematti P., Stratta R.J., Burke G.W. III, Di
Cocco P., Pisani F., Soker S., Wood K. Clinical operational tolerance
after renal transplantation: current status and future challenges. Ann.
Surg. 2010. 252. 915-928.
9. Goldman M., Wood K. Transplantation research: will we ever
reach the holy grail? Transplantation. 2009 May 15. 87(suppl. 9).
S99-100.
10. Owen R.D. Immunogenetic consequences of vascular anastomoses
between bovine twins. Science. 1945. 102. 400-1. doi: 10.1126/
science.102.2651.400.
11. Brent L. The discovery of immunologic tolerance. Hum. Immunol.
1997. 52. 75-81. doi: 10.1016/S0198-8859(96)00289-3.
12. Ge W., Jiang J., Arp J., Liu W., Garcia B., Wang H. Regulatory
T-cell generation and kidney allograft tolerance induced by
mesenchymal stem cells associated with indoleamine 2,3-dioxygenase
expression. Transplantation. 2010. 90. 1312-20. doi: 10.1097/
TP.0b013e3181fed001.
13. Collins E., Gu F., Qi M., Molano I., Ruiz P., Sun L. et al.
Differential efficacy of human mesenchymal stem cells based on
source of origin. J. Immunol. 2014. 193. 4381-90. doi: 10.4049/jimmunol.1401636.
14. Qi H., Chen G., Huang Y., Si Z., Li J. Foxp3-modified bone
marrow mesenchymal stem cells promotes liver allograft tolerance
through the generation of regulatory T cells in rats. J. Transl. Med.
2015. 13. 274. doi: 10.1186/s12967-015-0638-2.
15. Feng S., Ekong U.D., Lobritto S.J., Demetris A.J., Roberts
J.P., Rosenthal P., Alonso E.M., Philogene M.C., Ikle D.,
Poole K.M., Bridges N.D., Turka L.A., Tchao N.K. Complete immunosuppression
withdrawal and subsequent allograft function among
pediatric recipients of parental living donor liver transplants. JAMA.
2012. 307. 283-293.
16. Levitsky J. Operational tolerance: past lessons and future
prospects. Liver transplantation. 2011. 17. 222-232.
17. Afzali B., Lechler R.I., Hernandez-Fuentes M.P. Allorecognition
and the alloresponse: clinical implications. Tissue Antigens. 2007.
69. 545-556.
18. Lamb K.E., Lodhi S., Meier-Kriesche H.U. Long-term renal
allograft survival in the United States: a critical reappraisal. Am. J.
Transplant. 2011. 11. 450-462.
19. Lodhi S.A., Lamb K.E., Meier-Kriesche H.U. Solid organ allograft
survival improvement in the United States: the long-term does
not mirror the dramatic short-term success. Am. J. Transplant. 2011.
11. 1226-1235.
20. Newell K.A., Phippard D., Turka L.A. Regulatory cells and
cell signatures in clinical transplantation tolerance. Curr. Opin. Immunol.
2011. 23. 655-659.
21. Francis R.S., Feng G., Tha-In T., Lyons I.S., Wood K.J.,
Bushell A. Induction of transplantation tolerance converts potential effector
T cells into graft-protective regulatory T cells. Eur. J. Immunol.
2011. 41. 726-738.
22. Feng G., Wood K.J., Bushell A. Interferon-gamma conditioning
ex vivo generates CD25+CD62L+Foxp3+ regulatory T cells
that prevent allograft rejection: potential avenues for cellular therapy.
Transplantation. 2008. 86. 578-589.
23. Page E., Kwun J., Oh B., Knechtle S. Lymphodepletional
strategies in transplantation. Cold Spring Harb. Perspect. Med. 2013.
3. pii: a015511.
24. Groux H., O’Garra A., Bigler M., Rouleau M., Antonenko S.,
de Vries J.E., Roncarolo M.G. A CD4+ T-cell subset inhibits antigenspecific
T-cell responses and prevents colitis. Nature. 1997. 389. 737-
742.
25. Faria A.M., Weiner H.L. Oral tolerance. Immunol. Rev.
2005. 206. 232-259.
26. Vlad G., Cortesini R., Suciu-Foca N. CD8+ T suppressor cells
and the ILT3 master switch. Hum. Immunol. 2008. 69. 681-686.
27. Zhang Z.X., Yang L., Young K.J., DuTemple B., Zhang L.
Identification of a previously unknown antigen-specific regulatory
T cell and its mechanism of suppression. Nat. Med. 2000. 6.
782-789.
28. Seino K.I., Fukao K., Muramoto K., Yanagisawa K., Takada
Y., Kakuta S., Iwakura Y., Van Kaer L., Takeda K., Nakayama
T., Taniguchi M., Bashuda H., Yagita H., Okumura K. Requirement.
2001.
29. Starzl T.E., Marchioro T.L., Waddell W.R. The reversal
of rejection in human renal homografts with subsequent development
of homograft tolerance. Surg. Gynecol. Obstet. 1963. 117.
385-395.
30. Meier-Kriesche H.U., Schold J.D., Kaplan B. Long-term renal
allograft survival: have we made significant progress or is it time
to rethink our analytic and therapeutic strategies? Am. J. Transplant.
2004. 4. 1289-1295.
31. Womer K.L., Kaplan B. Recent developments in kidney transplantation
— a critical assessment. Am. J. Transplant. 2009. 9. 1265-
1271.
32. Markmann J. Immunosuppression with antithymocyte globulin,
rituximab, tacrolimus, and sirolimus, followed by withdrawal of
tacrolimus and sirolimus, in living-donor renal transplant recipients.
National Institute of Allergy and Infectious Diseases (NIAID). ClinicalTrials.gov
identifier: NCT01318915. Bethesda, MD: National Library
of Medicine. 2011.
14 Íèðêè, ISSN 2307-1257 (print), ISSN 2307-1265 (online) Òîì 10, ¹ 3, 2021